UnknownPhase 2

Treatment of TNNT1-Myopathy With L-Tyrosine.

Israel10 participantsStarted 2014-01

Plain-language summary

The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female patients * any age with TNNT1-related myopathy Exclusion Criteria: * Patients who are non-cooperative or parents/ legal guardians who are unwilling to sign consent form

What they're measuring

1. goal attainment score

Timeframe: 3 month

Trial details

NCT IDNCT02035501

SponsorHadassah Medical Organization

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-01

View on ClinicalTrials.gov More Nemaline Myopathy trials